The Claim
Fecal microbiota transplantation from atherosclerosis-prone donors increases the size and severity of atherosclerotic lesions in germ-free mice, indicating that microbial phenotypes associated with atherosclerosis can be transmitted and contribute to vascular disease progression in this model.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Transplanting gut bacteria from mice prone to artery disease into germ-free mice causes larger and more severe artery lesions, showing that these disease-associated bacteria can be transferred and directly contribute to vascular damage.
See the scientific wording
Fecal microbiota transplantation from atherosclerosis-prone donors exacerbates atherosclerotic lesions in germ-free mice, demonstrating that atherogenic microbial phenotypes are transmissible and suggesting a causal role for gut microbiota in experimental models of vascular disease.
Bad bacteria in the gut break down food into chemicals that enter the blood, triggering inflammation in blood vessels. These chemicals make immune cells stick to vessel walls, build up fatty plaques, and cause those plaques to become unstable. The same bad bacteria also weaken the gut lining, letting more inflammatory chemicals leak into the blood, which keeps the inflammation going and makes plaques grow larger.
What the research says
1 studyThis study doesn’t do the mouse transplant experiment itself, but it says other experiments have shown that bad gut bacteria from people with artery disease can make mice get worse plaque — and it backs up that idea with solid science.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.